These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25543078)

  • 1. Immunomodulatory effects of chitin microparticles on Leishmania major-infected BALB/c mice.
    Ghotloo S; Hoseini MH; Alimohammadian MH; Khaze V; Memarnejadian A; Rostami A
    Parasitol Int; 2015 Apr; 64(2):219-21. PubMed ID: 25543078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory activities of chitin microparticles on Leishmania major-infected murine macrophages.
    Dehghani F; Haji Molla Hoseini M; Memarnejadian A; Yeganeh F; Rezaie AM; Khaze V; Sattari M; Darbandi Tamijani H; Labibi F; Mossaffa N
    Arch Med Res; 2011 Oct; 42(7):572-6. PubMed ID: 22154683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection.
    Hoseini MH; Moradi M; Alimohammadian MH; Shahgoli VK; Darabi H; Rostami A
    Parasitol Int; 2016 Apr; 65(2):99-104. PubMed ID: 26518128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A candidate vaccine composed of live nonpathogenic Iranian Lizard Leishmania mixed with Chitin microparticles protects mice against Leishmania major infection.
    Haghdoust S; Noroozbeygi M; Hajimollahoseini M; Masooleh MM; Yeganeh F
    Acta Trop; 2022 Mar; 227():106298. PubMed ID: 34971566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the long-term and short-term protection in mouse model of Leishmania major infection following vaccination with Live Iranian Lizard Leishmania mixed with chitin microparticles.
    Noroozbeygi M; Keshavarzian N; Haji Molla Hoseini M; Haghdoust S; Yeganeh F
    Parasite Immunol; 2024 Jan; 46(1):e13018. PubMed ID: 37987175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
    J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitin Micro Particles Regulate Splenocytes Immune Response in Experimental Autoimmune Encephalomyelitis.
    Mami S; Yeganeh F; Farahani E; Anissian A; Haji Molla Hoseini M
    Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):190-199. PubMed ID: 31066255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis.
    Ramírez L; Santos DM; Souza AP; Coelho EA; Barral A; Alonso C; Escutia MR; Bonay P; de Oliveira CI; Soto M
    Vaccine; 2013 Feb; 31(9):1312-9. PubMed ID: 23313653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adjuvant effects of IL-12 and BCG on autoclaved Leishmania major vaccine in experimental cutaneous leishmaniasis.
    Michel MY; Fathy FM; Hegazy EH; Hussein ED; Eissa MM; Said DE
    J Egypt Soc Parasitol; 2006 Apr; 36(1):159-76, following 76. PubMed ID: 16605109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice.
    Gessner A; Blum H; Röllinghoff M
    Immunobiology; 1993 Dec; 189(5):419-35. PubMed ID: 8125519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody.
    Nabors GS; Farrell JP
    Am J Trop Med Hyg; 1995 Jul; 53(1):55-60. PubMed ID: 7625533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.
    Zadeh-Vakili A; Taheri T; Taslimi Y; Doustdari F; Salmanian AH; Rafati S
    Vaccine; 2004 May; 22(15-16):1930-40. PubMed ID: 15121305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
    Shankar AH; Morin P; Titus RG
    Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells.
    Krishnan L; Guilbert LJ; Wegmann TG; Belosevic M; Mosmann TR
    J Immunol; 1996 Jan; 156(2):653-62. PubMed ID: 8543817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
    Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
    J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coinfection with Listeria monocytogenes potentlxtes the response of BALB/c mice against Leishmania major.
    Tabbara KS; Al-Azmi AS; Al Salem JA
    J Egypt Soc Parasitol; 2004 Apr; 34(1):349-66. PubMed ID: 15125539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis.
    Abdian N; Gholami E; Zahedifard F; Safaee N; Rafati S
    Exp Parasitol; 2011 Mar; 127(3):627-36. PubMed ID: 21187087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania major: targeting IL-4 in successful immunomodulation of murine infection.
    Wakil AE; Wang ZE; Locksley RM
    Exp Parasitol; 1996 Nov; 84(2):214-22. PubMed ID: 8932771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.